International research consortium activates clinical study for novel coronavirus in England and Scotland

Patient enrolment begins in PARTNERS trial to identify the first effective treatments for Bundibugyo virus disease

2 July 2026

Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD). The trial is led in the DRC by the Institute National pour la Recherche Biomedicale, supported by the Institute of Tropical Medicine in Belgium, Ministry of Public Health of the Democratic Republic of the Congo, ALIMA (The Alliance for International Medical Action) and outbreak response teams from Médecins Sans Frontières (MSF). International trial coordination is led by the Pandemic Sciences Institute at the University of Oxford.

Professor Le Van Tan appointed Interim Director of OUCRU Ho Chi Minh City

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases

Academy of Medical Sciences elects three researchers from the Nuffield Department of Medicine as new Fellows